121 related articles for article (PubMed ID: 15200425)
1. Differential effects of simvastatin on mesangial cells.
Heusinger-Ribeiro J; Fischer B; Goppelt-Struebe M
Kidney Int; 2004 Jul; 66(1):187-95. PubMed ID: 15200425
[TBL] [Abstract][Full Text] [Related]
2. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
3. Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins).
Goppelt-Struebe M; Hahn A; Iwanciw D; Rehm M; Banas B
Mol Pathol; 2001 Jun; 54(3):176-9. PubMed ID: 11376131
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.
Crean JK; Furlong F; Finlay D; Mitchell D; Murphy M; Conway B; Brady HR; Godson C; Martin F
FASEB J; 2004 Oct; 18(13):1541-3. PubMed ID: 15319369
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics.
Nagasawa K; Muraki Y; Matsuda T; Ohnishi N; Yokoyama T
J Pharm Sci; 2000 Dec; 89(12):1594-604. PubMed ID: 11042608
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
8. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
10. Effects of fungal statins on high-glucose-induced mouse mesangial cell hypocontractility may involve filamentous actin, t-complex polypeptide 1 subunit beta, and glucose regulated protein 78.
Hwang JC; Chang LC; Lin YF; Shui HA; Chen JS
Transl Res; 2010 Aug; 156(2):80-90. PubMed ID: 20627192
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
Ghosh PM; Mott GE; Ghosh-Choudhury N; Radnik RA; Stapleton ML; Ghidoni JJ; Kreisberg JI
Biochim Biophys Acta; 1997 Oct; 1359(1):13-24. PubMed ID: 9398081
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
13. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
Nogaki F; Muso E; Yashiro M; Kasuno K; Kamata T; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S198-201. PubMed ID: 10412775
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton.
Ott C; Iwanciw D; Graness A; Giehl K; Goppelt-Struebe M
J Biol Chem; 2003 Nov; 278(45):44305-11. PubMed ID: 12951326
[TBL] [Abstract][Full Text] [Related]
16. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
17. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
18. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
Watts KL; Cottrell E; Hoban PR; Spiteri MA
Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress.
Cicha I; Goppelt-Struebe M; Muehlich S; Yilmaz A; Raaz D; Daniel WG; Garlichs CD
Atherosclerosis; 2008 Jan; 196(1):136-145. PubMed ID: 17452038
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
